CAS RN: 2216763-38-9
Rheb inhibitor NR1
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250406
1mg / 5mg / 25mg / 100mg / 250mg
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2216763-38-9
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
2216763-38-9 / 4-bromo-6-(3,4-dichlorophenyl)sulfanyl-1-[[4-(dimethylcarbamoyl)phenyl]methyl]indole-2-carboxylic acid
Standard CAS: 2216763-38-9
Multi CAS: No
Basic Information
copy
CAS
2216763-38-9 copy
Multi CAS
No copy
Molecular Formula
C25H19BrCl2N2O3S copy
Molecular Weight
578.300000 copy
Exact Mass
575.967680 copy
SMILES
CN(C)C(=O)C1=CC=C(C=C1)CN2C(=CC3=C2C=C(C=C3Br)SC4=CC(=C(C=C4)Cl)Cl)C(=O)O copy
InChI
InChI=1S/C25H19BrCl2N2O3S/c1-29(2)24(31)15-5-3-14(4-6-15)13-30-22-11-17(34-16-7-8-20(27)21(28)10-16)9-19(26)18(22)12-23(30)25(32)33/h3-12H,13H2,1-2H3,(H,32,33) copy
InChIKey
MJYFVDNMTKLGTH-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
34 copy
Aromatic heavy atom count
21 copy
Fraction Csp3
0.12 copy
Rotatable bonds
6 copy
H-bond acceptors
4 copy
H-bond donors
1 copy
Molar refractivity
140.74 copy
TPSA
62.54 copy
LogP / Solubility
WLOGP
7.31 copy
MLOGP
6.48 copy
XLogP3
6.9 copy
Consensus LogP
6.9 copy
Log S (ESOL)
-8.09 copy
Class (ESOL)
Insoluble copy
Log S (Ali)
-9.58 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-10.21 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-1.06 copy
Drug-likeness / Medicinal Chemistry
Lipinski
No copy
Ghose
No copy
Veber
Yes copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.17 copy
Leadlikeness
No copy
Synthetic Accessibility
3 copy